426 related articles for article (PubMed ID: 23942292)
21. Eradication of Helicobacter pylori and stability of remissions in low-grade gastric B-cell lymphomas of the mucosa-associated lymphoid tissue: results of an ongoing multicenter trial.
Thiede C; Wündisch T; Neubauer B; Alpen B; Morgner A; Ritter M; Ehninger G; Stolte M; Bayerdörffer E; Neubauer A
Recent Results Cancer Res; 2000; 156():125-33. PubMed ID: 10802872
[TBL] [Abstract][Full Text] [Related]
22. Are antibiotics the treatment of choice for gastric lymphoma?
Zucca E; Cavalli F
Curr Hematol Rep; 2004 Jan; 3(1):11-6. PubMed ID: 14695844
[TBL] [Abstract][Full Text] [Related]
23. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a clinicopathologic and molecular study with reference to antibiotic treatment.
Nakamura S; Matsumoto T; Ye H; Nakamura S; Suekane H; Matsumoto H; Yao T; Tsuneyoshi M; Du MQ; Iida M
Cancer; 2006 Dec; 107(12):2770-8. PubMed ID: 17099876
[TBL] [Abstract][Full Text] [Related]
24. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
Levy M; Copie-Bergman C; Traulle C; Lavergne-Slove A; Brousse N; Flejou JF; de Mascarel A; Hemery F; Gaulard P; Delchier JC;
Am J Gastroenterol; 2002 Feb; 97(2):292-7. PubMed ID: 11866264
[TBL] [Abstract][Full Text] [Related]
25. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series.
Fischbach W; Goebeler-Kolve ME; Dragosics B; Greiner A; Stolte M
Gut; 2004 Jan; 53(1):34-7. PubMed ID: 14684573
[TBL] [Abstract][Full Text] [Related]
26. Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach.
Chen LT; Lin JT; Shyu RY; Jan CM; Chen CL; Chiang IP; Liu SM; Su IJ; Cheng AL
J Clin Oncol; 2001 Nov; 19(22):4245-51. PubMed ID: 11709568
[TBL] [Abstract][Full Text] [Related]
27. Primary gastric lymphoma.
Isaacson PG
Br J Biomed Sci; 1995 Dec; 52(4):291-6. PubMed ID: 8555783
[TBL] [Abstract][Full Text] [Related]
28. Association between Helicobacter pylori infection and MALT-type lymphoma of the ocular adnexa: clinical and therapeutic implications.
Ferreri AJ; Ponzoni M; Viale E; Guidoboni M; Conciliis CD; Resti AG; Politi L; Lettini AA; Sacchetti F; Dognini G; Dolcetti R; Doglioni C
Hematol Oncol; 2006 Mar; 24(1):33-7. PubMed ID: 16385613
[TBL] [Abstract][Full Text] [Related]
29. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue.
Roggero E; Zucca E; Pinotti G; Pascarella A; Capella C; Savio A; Pedrinis E; Paterlini A; Venco A; Cavalli F
Ann Intern Med; 1995 May; 122(10):767-9. PubMed ID: 7717599
[TBL] [Abstract][Full Text] [Related]
30. Molecular diagnostics in low-grade gastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type after Helicobacter pylori eradication therapy.
Alpen B; Thiede C; Wündisch T; Bayerdörffer E; Stolte M; Neubauer A
Clin Lymphoma; 2001 Sep; 2(2):103-8. PubMed ID: 11707850
[TBL] [Abstract][Full Text] [Related]
31. Regression of low-grade gastric mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: possible association with p16 hypermethylation.
Kim YS; Kim JS; Jung HC; Lee CH; Kim CW; Song IS; Kim CY
J Gastroenterol; 2002 Jan; 37(1):17-22. PubMed ID: 11824795
[TBL] [Abstract][Full Text] [Related]
32. Changes in pattern of immunoglobulin heavy chain gene rearrangement and MIB-1 staining before and after eradication of Helicobacter pylori in gastric mucosa-associated lymphoid tissue (MALT) lymphoma.
Kanda M; Suzumiya J; Ohshima K; Okada M; Tamura K; Kikuchi M
Leuk Lymphoma; 2001 Aug; 42(4):639-47. PubMed ID: 11697492
[TBL] [Abstract][Full Text] [Related]
33. Regression of colonic low grade B cell lymphoma of the mucosa associated lymphoid tissue type after eradication of Helicobacter pylori.
Raderer M; Pfeffel F; Pohl G; Mannhalter C; Valencak J; Chott A
Gut; 2000 Jan; 46(1):133-5. PubMed ID: 10601069
[TBL] [Abstract][Full Text] [Related]
34. Helicobacter pylori eradication therapy in primary high-grade gastric MALT lymphoma.
Fischbach W
Gastroenterology; 2002 Jul; 123(1):393. PubMed ID: 12105882
[No Abstract] [Full Text] [Related]
35. Antibodies to Helicobacter pylori and CagA protein are associated with the response to antibacterial therapy in patients with H. pylori-positive API2-MALT1-negative gastric MALT lymphoma.
Sumida T; Kitadai Y; Hiyama T; Shinagawa K; Tanaka M; Kodama M; Masuda H; Ito M; Tanaka S; Yoshihara M; Chayama K
Cancer Sci; 2009 Jun; 100(6):1075-81. PubMed ID: 19385974
[TBL] [Abstract][Full Text] [Related]
36. Long-term follow-up of gastric MALT lymphoma after H. pylori eradication.
Morgner A; Thiede C; Bayerdörffer E; Alpen B; Wündisch T; Neubauer A; Stolte M
Curr Gastroenterol Rep; 2001 Dec; 3(6):516-22. PubMed ID: 11696290
[TBL] [Abstract][Full Text] [Related]
37. Helicobacter pylori eradication therapy for high-grade mucosa-associated lymphoid tissue lymphomas of the stomach with analysis of p53 and K-ras alteration and microsatellite instability.
Hiyama T; Haruma K; Kitadai Y; Ito M; Masuda H; Miyamoto M; Tanaka S; Yoshihara M; Sumii K; Shimamoto F; Chayama K
Int J Oncol; 2001 Jun; 18(6):1207-12. PubMed ID: 11351252
[TBL] [Abstract][Full Text] [Related]
38. Long term follow up of Helicobacter pylori induced gastric diffuse large B cell MALT lymphoma following eradication treatment alone.
Sinharay R
Gut; 2003 Sep; 52(9):1385. PubMed ID: 12912879
[No Abstract] [Full Text] [Related]
39. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy.
Liu H; Ruskon-Fourmestraux A; Lavergne-Slove A; Ye H; Molina T; Bouhnik Y; Hamoudi RA; Diss TC; Dogan A; Megraud F; Rambaud JC; Du MQ; Isaacson PG
Lancet; 2001 Jan; 357(9249):39-40. PubMed ID: 11197361
[TBL] [Abstract][Full Text] [Related]
40. Long-term follow-up of gastric MALT lymphoma treated by eradication of H. pylori with antibodies.
Isaacson PG; Diss TC; Wotherspoon AC; Barbazza R; De Boni M; Doglioni C
Gastroenterology; 1999 Sep; 117(3):750-1. PubMed ID: 10490369
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
